Atlas Venture Fund Ix, L.P. Insider Trades

Insider Trading History

Track insider trading activity for Atlas Venture Fund Ix, L.P.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Surface Oncology
Surface Oncology SURF
10% owner
Holding Value $3.15M 2,945,453 shares
Last Trade
Dec 17, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.8M 1,700,000 shares
$8.10
$1.07
Surface Oncology
Surface Oncology SURF
10% owner
Holding Value $0 0 shares
Last Trade
Apr 23, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$90.2M 7,000,000 shares
$12.88
$1.07
Surface Oncology
Surface Oncology SURF
10% owner
Holding Value $4.97M 4,645,453 shares
Last Trade
Apr 23, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.29M 100,000 shares
$12.88
$1.07
Surface Oncology
Surface Oncology SURF
10% owner
Holding Value $4.86M 4,545,453 shares
Last Trade
Apr 23, 2018 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$41M 3,181,817 shares
$12.88
$1.07
Surface Oncology
Surface Oncology SURF
10% owner
Holding Value $0 0 shares
Last Trade
Apr 18, 2018 Sale
No data
No data
$1.07
Cogent Biosciences
Cogent Biosciences COGT
10% owner
Holding Value $0 0 shares
Last Trade
Apr 03, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$893k 83,037 shares
$10.75
$32.26
Cogent Biosciences
Cogent Biosciences COGT
10% owner
Holding Value $0 0 shares
Last Trade
Apr 03, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$34.2M 3,184,446 shares
$10.75
$32.26
Cogent Biosciences
Cogent Biosciences COGT
10% owner
Holding Value $103M 3,184,446 shares
Last Trade
Apr 03, 2018 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$34.2M 3,184,446 shares
$10.75
$32.26
Cogent Biosciences
Cogent Biosciences COGT
10% owner
Holding Value $108M 3,361,535 shares
Last Trade
Apr 03, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.01M 94,052 shares
$10.75
$32.26
Cogent Biosciences
Cogent Biosciences COGT
10% owner
Holding Value $105M 3,267,483 shares
Last Trade
Apr 03, 2018 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$893k 83,037 shares
$10.75
$32.26
Cogent Biosciences
Cogent Biosciences COGT
10% owner
Holding Value $0 0 shares
Last Trade
Mar 28, 2018 Sale
No data
No data
$32.26
Spero Therapeutics
Spero Therapeutics SPRO
10% owner
Holding Value $0 0 shares
Last Trade
Nov 01, 2017 Sale
$473k 246,272 shares
$1.92
$2.80
Spero Therapeutics
Spero Therapeutics SPRO
10% owner
Holding Value $0 0 shares
Last Trade
Nov 01, 2017 Sale
$632k 328,992 shares
$1.92
$2.80
Spero Therapeutics
Spero Therapeutics SPRO
10% owner
Holding Value $0 0 shares
Last Trade
Nov 01, 2017 Sale
$472k 245,605 shares
$1.92
$2.80
Spero Therapeutics
Spero Therapeutics SPRO
10% owner
Holding Value $0 0 shares
Last Trade
Nov 01, 2017 Sale
$986k 513,318 shares
$1.92
$2.80
Intellia Therapeutics
Intellia Therapeutics NTLA
10% owner
Holding Value $46.6M 3,579,788 shares
Last Trade
Jul 11, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.29M 80,000 shares
$16.07
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
10% owner
Holding Value $47.7M 3,659,788 shares
Last Trade
Jul 10, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$647k 40,000 shares
$16.17
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
10% owner
Holding Value $48.2M 3,699,788 shares
Last Trade
Jul 07, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$503k 30,000 shares
$16.77
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
10% owner
Holding Value $48.6M 3,729,788 shares
Last Trade
Mar 03, 2017 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$9.69M 700,000 shares
$13.84
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
10% owner
Holding Value $0 0 shares
Last Trade
May 11, 2016 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$96.2M 3,809,524 shares
$25.25
$13.02

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up